Digital Health Monthly: Scientific Webinar Series
Combining Active and Passive DHT Monitoring to Accelerate Neurology Drug Development
Wednesday, March 26, 2025 @ 12 PM ET
Upcoming Digital Health Monthly:
Scientific Webinar Series
Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies
Tuesday, December 3 @ 12 PM ET
Digital Health Monthly: Scientific Webinar Series
Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.
As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.
There is a robust drug development pipeline for neurological diseases such as Parkinson’s disease and Alzheimer’s disease, but many of these treatments fail to transition from Phase 2 to Phase 3, raising the question – are these treatments ineffective, or are the current efficacy measurements not sensitive enough?
Digital health technologies can more accurately assess daily patient function in neurology trials, increasing the sensitivity of outcome measures in clinical trials. In this Digital Health Monthly webinar, we’ll discuss a new scientific partnership between ActiGraph and Indivi combining both active and passive digital measures.
We’ll discuss how active and passive digital measures can remotely track motor and non-motor symptoms more frequently for a comprehensive view of patients' capacity, perception, and performance that is critical for evaluating new therapies for these multifaceted conditions. We’ll also review the scientific, analytical, and operational expertise that supports this new digital health solution for neurology clinical trials.
Speakers
